Dr. Alexanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
732 Harrison Ave FL 2
Preston Bldg
Boston, MA 02118Phone+1 617-638-7470Fax+1 617-638-7449
Education & Training
- Boston University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2008
- Mount Auburn HospitalResidency, Internal Medicine, 2003 - 2006
- Geisel School of Medicine at DartmouthClass of 2003
Certifications & Licensure
- MA State Medical License 2005 - 2026
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus Start of enrollment: 2020 Dec 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Impact of Meal Insulin Bolus Timing and Bedtime Snacking on Continuous Glucose Monitoring-Derived Glycemic Metrics in Hospitalized Inpatients.Sara M Alexanian, Michael C Cheney, Jenny C Bello Ramos, Nicole L Spartano, Howard A Wolpert
Diabetes Technology & Therapeutics. 2025-03-11 - Comparing Postprandial Glycemic Control Using Fiasp vs Insulin Aspart in Hospitalized Patients With Type 2 Diabetes.Sara M Alexanian, Michael C Cheney, Nicole L Spartano, Jenny C Bello-Ramos, Niyoti Reddy
Endocrine Practice. 2025-03-01 - 1 citationsGaps in the type 2 diabetes care cascade: a national perspective using South Africa's National Health Laboratory Service (NHLS) database.Alana T Brennan, Evelyn Lauren, Jacob Bor, Jaya A George, Kamy Chetty
BMC Health Services Research. 2023-12-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: